Team announcement

Cognate appoints Tim Moore, Steven Kasok to its Board

Cognate appoints Tim Moore, Steven Kasok to its Board, Cognate BioServices

Biotech company Cognate BioServices, Inc has appointed Tim Moore and Steven Kasok to its Board of Directors as non-executive members.

Mr. Moore is President and Chief Operating Officer of Pact Pharma, and has more than 30 years of experience leading biopharmaceutical manufacturing companies. He has worked across product development, manufacturing, quality and supply chain roles, is a current member of ISPE, PDA, and also serves as a Board member for Cerus.

Mr. Kasok was a co-founder, board member and Chief Financial Officer of CDMO company Brammer Bio, bringing considerable experience to Cognate. He also co-founded Gallus BioPharmaceuticals, another CDMO, and has expertise in financial, human resources, IT and legal roles.

"We are excited to welcome Tim Moore and Steve Kasok to our Board of Directors,” said Cognate CEO and Board Chairman J. Kelly Ganjei. “They bring decades of leadership in key commercial areas of cell and gene therapy. We are thrilled to be able to work with them as we aggressively scale the business to meet the needs of our clients. Tim and Steve's counsel and expertise will bring additional highly relevant experience to our Board and help strengthen Cognate's core competencies in the commercial scale-up of its global operations, ultimately to better serve our clients and the patients they serve."

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.